Jean‐Paul Albenque
Jean‐Paul Albenque publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Biotechnology, on topics such as Cardiac Arrhythmias and Treatments, Atrial Fibrillation Management and Outcomes and Cardiac pacing and defibrillation studies.
- World rank
- #798,068 of 7,710,434 ranked researchers
- Rank in France
- #38,737 of 324,115
- Works
- 85
- Citations
- 4.6k
- Citations per work
- 54.6
What does Jean‐Paul Albenque research?
Jean‐Paul Albenque's work is mostly in Medicine (91%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7891.2%
- Medicine7891.2%
- Everything else56.3%
- Life Sciences22.5%
- 1Cardiology and Cardiovascular Medicine86% of their works
- 2Surgery3% of their works
- 3Biotechnology2% of their works
- 4Pulmonary and Respiratory Medicine1% of their works
- 5Molecular Biology1% of their works
- 6Epidemiology1% of their works
Research topics
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Microbial Inactivation Methods
- Cardiovascular Function and Risk Factors
- Pericarditis and Cardiac Tamponade
- Cardiovascular Syncope and Autonomic Disorders
Which keywords describe Jean‐Paul Albenque's research?
The keywords of their largest research topics: Catheter Ablation, Arrhythmias, Radiofrequency Ablation, Ventricular Tachycardia, Anticoagulant Therapy, Atrial Fibrillation, Sudden Cardiac Death and Echocardiography.
- Orthostatic Hypotension
- Irreversible Electroporation
- Diastolic Function
- Chamber Quantification
- Ion Channels
- Cardiac Resynchronization Therapy
- Echocardiography
- Atrial Fibrillation
- Ventricular Tachycardia
- Arrhythmias
- Catheter Ablation
- Radiofrequency Ablation
- Anticoagulant Therapy
- Sudden Cardiac Death
- Heart Failure
- Implantable Cardioverter-Defibrillator
- Long-QT Syndrome
- Constrictive Pericarditis
- Electroporation
- Pericarditis
- Syncope
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Catheter Ablation1362 topics
- Arrhythmias862 topics
- Radiofrequency Ablation711 topic
- Ventricular Tachycardia711 topic
- Anticoagulant Therapy651 topic
- Atrial Fibrillation651 topic
- Sudden Cardiac Death532 topics
- Echocardiography463 topics
- Heart Failure422 topics
- Cardiac Resynchronization Therapy381 topic
- Implantable Cardioverter-Defibrillator381 topic
- Ion Channels151 topic
- Long-QT Syndrome151 topic
- Chamber Quantification41 topic
- Constrictive Pericarditis41 topic
- Diastolic Function41 topic
- Electroporation41 topic
- Irreversible Electroporation41 topic
- Pericarditis41 topic
- Orthostatic Hypotension31 topic
- Syncope31 topic
Where does Jean‐Paul Albenque work?
Jean‐Paul Albenque's main affiliation in the publication record is Clinique Pasteur, France.
How many publications and citations does Jean‐Paul Albenque have?
OpenAlex counts 85 works and 4,643 citations for Jean‐Paul Albenque, an h-index of 27, ranking #798,068 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jean‐Paul Albenque
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jean‐Paul Albenque. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.